Iatrogenic demyelinating disorders: New insights, new culprits

Hesham Abboud

doi:10.1177/1352458519895445

Iatrogenic demyelinating disorders: New insights, new culprits

Mult Scler. 2020 Aug;26(9):1129-1130. doi: 10.1177/1352458519895445. Epub 2019 Dec 17.

Author

Hesham Abboud¹

Affiliation

¹ Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center Bolwell, Cleveland, OH, USA.

PMID: 31845617
DOI: 10.1177/1352458519895445

No abstract available

Keywords: Iatrogenic; biologics; demyelination; multiple sclerosis; neuromyelitis optica; tumor necrosis factor alpha inhibitors; tyrosine kinase inhibitors.

Publication types

Comment

MeSH terms

Humans
Iatrogenic Disease
Infliximab
Multiple Sclerosis*
Neuromyelitis Optica*

Substances

Infliximab